Scott R. Manalis

Scott R. Manalis

Auto-generated profile, based on publicly available information

Scott R. Manalis

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology 1 , Cambridge, MA 02139

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Cell
Verified
Journal Article
Open access
SRSrivatsan Raghavan
Srivatsan Raghavan
PWPeter S. Winter
Peter S. Winter
ANAndrew W. Navia
Andrew W. Navia
HWHannah L. Williams
Hannah L. Williams
ADAlan DenAdel
Alan DenAdel
ASAlex K. Shalek
Alex K. Shalek
Prognostically relevant RNA expression states exist in pancreatic ductal adenocarcinoma (PDAC), but our understanding of their drivers, stability, and relationship to therapeutic response is limited. To examine these attributes systematically, we profiled metastatic biopsies and matched organoid models at single-cell resolution. In vivo, we identify a new intermediate PDAC transcriptional cell state and uncover distinct site- and state-specific tumor microenvironments (TMEs). Benchmarking models against this reference map, we reveal strong culture-specific biases in cancer cell transcriptional state representation driven by altered TME signals. We restore expression state heterogeneity by adding back in vivo-relevant factors and show plasticity in culture models. Further, we prove that non-genetic modulation of cell state can strongly influence drug responses, uncovering state-specific vulnerabilities. This work provides a broadly applicable framework for aligning cell states across in vivo and ex vivo settings, identifying drivers of transcriptional plasticity and manipulating cell state to target associated vulnerabilities.

27 April 2020 in Nature Methods
Verified
Journal Article
Closed access
PDF file
MUMarta Urbanska
Marta Urbanska
HMHector E. Muñoz
Hector E. Muñoz
JBJosephine Shaw Bagnall
Josephine Shaw Bagnall
OOOliver Otto
Oliver Otto
SMScott R. Manalis
Scott R. Manalis
JGJochen Guck
Jochen Guck

5 September 2016 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
NCNathan Cermak
Nathan Cermak
SOSelim Olcum
Selim Olcum
FDFrancisco Feijó Delgado
Francisco Feijó Delgado
SWSteven C Wasserman
Steven C Wasserman
KPKristofor R Payer
Kristofor R Payer
SMScott R Manalis
Scott R Manalis
Heterogeneity in growth phenotypes and drug susceptibility in bacterial and mammalian cells are assayed at the single-cell level using multiplexed resonant mass sensors. Methods to rapidly assess cell growth would be useful for many applications, including drug susceptibility testing, but current technologies have limited sensitivity or throughput. Here we present an approach to precisely and rapidly measure growth rates of many individual cells simultaneously. We flow cells in suspension through a microfluidic channel with 10–12 resonant mass sensors distributed along its length, weighing each cell repeatedly over the 4–20 min it spends in the channel. Because multiple cells traverse the channel at the same time, we obtain growth rates for >60 cells/h with a resolution of 0.2 pg/h for mammalian cells and 0.02 pg/h for bacteria. We measure the growth of single lymphocytic cells, mouse and human T cells, primary human leukemia cells, yeast, Escherichia coli and Enterococcus faecalis. Our system reveals subpopulations of cells with divergent growth kinetics and enables assessment of cellular responses to antibiotics and antimicrobial peptides within minutes.

23 November 2015 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
SSSungmin Son
Sungmin Son
JKJoon Ho Kang
Joon Ho Kang
SOSeungeun Oh
Seungeun Oh
MKMarc W. Kirschner
Marc W. Kirschner
TMT.J. Mitchison
T.J. Mitchison
SMScott Manalis
Scott Manalis
Osmotic regulation of intracellular water during mitosis is poorly understood because methods for monitoring relevant cellular physical properties with sufficient precision have been limited. Here we use a suspended microchannel resonator to monitor the volume and density of single cells in suspension with a precision of 1% and 0.03%, respectively. We find that for transformed murine lymphocytic leukemia and mouse pro–B cell lymphoid cell lines, mitotic cells reversibly increase their volume by more than 10% and decrease their density by 0.4% over a 20-min period. This response is correlated with the mitotic cell cycle but is not coupled to nuclear osmolytes released by nuclear envelope breakdown, chromatin condensation, or cytokinesis and does not result from endocytosis of the surrounding fluid. Inhibiting Na-H exchange eliminates the response. Although mitotic rounding of adherent cells is necessary for proper cell division, our observations that suspended cells undergo reversible swelling during mitosis suggest that regulation of intracellular water may be a more general component of mitosis than previously appreciated.

29 January 2018 in Nature Reviews Cancer
Verified
Journal Article
Open access
PDF file
MLMarlise R. Luskin
Marlise R. Luskin
MMMark A. Murakami
Mark A. Murakami
SMScott R. Manalis
Scott R. Manalis
DWDavid M. Weinstock
David M. Weinstock
Improved therapies have allowed many patients with cancer to achieve complete remission, but they retain minimal residual disease (MRD), which causes relapse. This Opinion article argues that iterative detection, profiling and targeting of MRD could improve outcomes, including cure rates. Therapeutics that block kinases, transcriptional modifiers, immune checkpoints and other biological vulnerabilities are transforming cancer treatment. As a result, many patients achieve dramatic responses, including complete radiographical or pathological remission, yet retain minimal residual disease (MRD), which results in relapse. New functional approaches can characterize clonal heterogeneity and predict therapeutic sensitivity of MRD at a single-cell level. Preliminary evidence suggests that iterative detection, profiling and targeting of MRD would meaningfully improve outcomes and may even lead to cure.

12 November 2021 in Science Advances
Verified
Journal Article
Open access
JLJette Lengefeld
Jette Lengefeld
CCChia-Wei Cheng
Chia-Wei Cheng
PMPema Maretich
Pema Maretich
MBMarguerite Blair
Marguerite Blair
HHHannah Hagen
Hannah Hagen
AAAngelika Amon
Angelika Amon
Small cell size preserves the function of hematopoietic stem cells (HSCs); HSC enlargement during aging causes their dysfunction.